April 26th 2024
A study finds that despite the development of some new agents for highly-resistant pathogens, prescribers are reluctant to utilize these therapies.
Is Eravacycline Ready for Prime Time Against CRAB Pneumonia?
September 22nd 2022Eravacycline is an antibiotic that has been touted for possible treatment of difficult-to-treat resistant (DTR) Gram-negative infections. But can it tackle carbapenem-resistant Acinetobacter baumannii (CRAB) infections?
Read More
Dentists Improve Antibiotic Prescribing after Antibiotic Stewardship Education
August 30th 2022Dentists write about 25.7 million prescriptions annually, amounting to about 10% of all outpatient antibiotic prescriptions in the United States. A recent study showed that educating dentists about the risks of antibiotics—including antimicrobial resistance and Clostridioides difficile infections—led to sharp decreases in prescriptions.
Read More
IV Push Administration for Outpatient Parenteral Antimicrobial Therapy
July 26th 2022Investigators designed a quasi-experimental pre- and post-intervention analysis comparing a pre-intervention cohort receiving IV drip antibiotic infusion with a post-intervention cohort receiving IVP administration.
Read More
Antibiotic Therapy Often Used Improperly in Kids with MIS-C Related to COVID-19
July 17th 2022Most children with multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19 receive improper antimicrobial treatment, according to a recent study that highlights an urgent need to improve diagnosis and treatment of the condition.
Read More